LS@W supports Life Sciences startups through the Venture Challenge, Expert Classes and Value Center programs. Startups that have participated in (one or more) of these programs are listed as LS@W alumni. In addition startups that have received an NGI Pre-Seed Grant, which was part of LS@W from 2007 - 2012, are listed as LS@W alumni.
The Venture Challenge is the most successful program for startups in the Life Sciences and Medical Technology. More than 25 editions of the Venture Challenge have been organised helping startups in Therapeutics, Diagnostics, Medical Devices and Enabling Technologies. Startups that have participated in the Venture Challenge and still exist are listed.
Pre-Seed Grant Alumni
In the first years of LifeSciences@Work the NGI Pre-Seed Grant was part of the program. Startups that have received a Pre-Seed Grant via the LS@W program and still exist are listed.
Stem cell technologies help bring better therapies to patients faster. Ncardia works with pharmaceutical and cell therapy companies worldwide to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities.
At NestEgg Labs, we simplify 3D cell culture through automation. We have developed Ovation, an automated platform capable of combining Lens-Free Imaging technology for constant cell monitoring and flexible fluid handling for cell maintenance inside a controlled environment, letting cells grow without unnecessary manual interference.
The UBM is a small wearable device that provides warning when the bladder is nearly full. UBM helps children to stay dry during day and night and will improve the effectiveness of continence training by teaching the child the sensation of a full bladder.
Novuxion offers a non-invasive, inexpensive method of testing patients. We aim to provide in vitro diagnostic technology to enable (early) detection of metastatic cancer, patient monitoring, and therapy adjustment.
OcellO offers in vitro assays which recapitulate and quantify complex human biology in a robust and high-throughput format.
We test compounds for oncology, immuno-oncology, inflammation and cystopathy indications.